Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: William Strop who wrote (449)	12/26/1997 10:55:00 PM
From: Scott H. Davis	Read Replies (2) \| Respond to of 1972

William & All: I've been following both VICL and ISIP for a while, and just sold enough shares of a fund to buy one. I realize that technically neither are looking good from a TA perspective. I've also been puzzled by the poor response to both companies releasing good news. Both are far better from a risk/reward ratio then they were at their highs. There is a very good chance I'll pick up some of each in the next few months. So the question I'd like to pose is, to the veterens on this thread, why would now be a good time to pick up on VICL. I realize that I'm asking for OPINIONS only, and will read whatever with a grain of salt, but it seems to me the combination of clinical trial results and partnerships is getting pretty compelling. Look forward to hearing from ya'll. Scott